Key Takeaways Global pharmaceutical shares jumped in intraday trading Monday, reversing their pre-market declines, as investors anticipated the challenges that may…
Read More »drug
The Food and Drug Administration’s approval in 2023 of lecanemab — a novel Alzheimer’s therapy shown in clinical trials to…
Read More »President Trump, joined by National Institutes of Health Director Jay Bhattacharya and Health and Human Services Secretary Robert F. Kennedy…
Read More »Key Takeaways President Donald Trump has ordered the government’s health insurance programs to pay the same price for medications as…
Read More »President Trump on Monday signed an executive order asking drugmakers to voluntarily reduce the prices of key medicines in the…
Read More »KEY TAKEAWAYS Global pharmaceutical shares are slumping Monday after President Donald Trump said he is looking to slash the price…
Read More »President Trump will sign an executive order on Monday aimed at lowering some drug prices in the United States by…
Read More »Tens of thousands of Americans will soon be forced by their heath insurance to switch from one popular obesity drug…
Read More »How well our brain functions depends heavily on the performance of our nerve cells. That is why they are regularly…
Read More »The Food and Drug Administration has been meeting with OpenAI to discuss the agency’s use of AI, according to sources…
Read More »